The primary outcome of the study was the demonstration of a decreased incidence of both AD, with a RR of 0.79 (95% CI 0.71–0.88), and IgE-associated AD, with a RR of 0.80 (95% CI 0.66–0.96). This evidence concerns the gene IGHE and Alzheimer disease.